Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALPI | P09923 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2796935 | 0.91 | MAPT (0.39) | KDM4EALDH1A1HPGDMAPK1SMN1; SMN2 | |
| SCHEMBL1120262 | 0.90 | KDM4E (0.36) | KDM4EALDH1A1HPGDMAPK1SMN1; SMN2 | |
| SCHEMBL1119997 | 0.90 | GRN (0.39) | KDM4EALDH1A1HPGDMAPK1SMN1; SMN2 | |
| SCHEMBL1120112 | 0.85 | GRN (0.37) | KDM4EALDH1A1HPGDMAPK1SMN1; SMN2 | |
| SCHEMBL15484996 | 0.84 | KDM4E (0.46) | KDM4EALDH1A1HPGDLMNAPOLB | |
| SCHEMBL12859148 | 0.80 | LMNA (0.31) | KDM4ELMNA | |
| SCHEMBL1120063 | 0.80 | KLKB1 (0.36) | KDM4EALDH1A1HPGDMAPK1SMN1; SMN2 | |
| SCHEMBL12859127 | 0.79 | MAP3K12 (0.38) | KDM4EALDH1A1LMNATSHRMAPT | |
| SCHEMBL14487490 | 0.78 | CRACR2A (0.44) | POLB | |
| SCHEMBL1120080 | 0.77 | KDM4E (0.37) | KDM4EALDH1A1HPGDMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150237859-A1 | Thiazol-4-Carboxylic Acid Esters and Thioesters as Plant Protection Agents | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-27 | — | — | US | disclosed |
| EP-2280965-B1 | THIAZOL-4-CARBOXYLIC ACID ESTERS AND THIOESTERS AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE AG (DE) | 2012-08-29 | — | — | EP | disclosed |
| US-20110105429-A1 | Thiazole-4-Carboxylic Acid Esters and Thioesters as Plant Protection Agents | BAYER CROPSCIENCE AG (DE) | 2011-05-05 | — | — | US | disclosed |
| EP-2280965-A1 | THIAZOL-4-CARBOXYLIC ACID ESTERS AND THIOESTERS AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE AG (DE) | 2011-02-09 | — | — | EP | disclosed |
| WO-2009132785-A1 | THIAZOL-4-CARBOXYLIC ACID ESTERS AND THIOESTERS AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT | 2009-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105429-A1 | Thiazole-4-Carboxylic Acid Esters and Thioesters as Plant Protection Agents | ACOT7, LYPLA1, PPT1 | KDM4E 1123/4885ALDH1A1 459/4885HPGD 3990/4885 |
| US-20150237859-A1 | Thiazol-4-Carboxylic Acid Esters and Thioesters as Plant Protection Agents | LYPLA1, ACOT7, PPT1 | KDM4E 1527/4885ALDH1A1 436/4885HPGD 3984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.